These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 20685321)
1. Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients. Einsiedel L; Cherry CL; Sheeran FL; Friedhuber A; Wesselingh SL; Pepe S Mitochondrion; 2010 Aug; 10(5):534-9. PubMed ID: 20685321 [TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients. Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557 [TBL] [Abstract][Full Text] [Related]
3. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932 [TBL] [Abstract][Full Text] [Related]
4. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy. Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366 [TBL] [Abstract][Full Text] [Related]
6. Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy. Cossarizza A; Riva A; Pinti M; Ammannato S; Fedeli P; Mussini C; Esposito R; Galli M Antivir Ther; 2003 Aug; 8(4):315-21. PubMed ID: 14518701 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy. Miró O; López S; Pedrol E; Rodríguez-Santiago B; Martínez E; Soler A; Milinkovic A; Casademont J; Nunes V; Gatell JM; Cardellach F Antivir Ther; 2003 Aug; 8(4):333-8. PubMed ID: 14526764 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179 [TBL] [Abstract][Full Text] [Related]
11. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells. Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467 [TBL] [Abstract][Full Text] [Related]
13. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688 [TBL] [Abstract][Full Text] [Related]
15. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Solinas P; Mannazzu M; Falchi A; Mura MS; Madeddu G Clin Endocrinol (Oxf); 2006 Apr; 64(4):375-83. PubMed ID: 16584508 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702 [TBL] [Abstract][Full Text] [Related]
17. The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients. Milinkovic A; Martinez E; López S; de Lazzari E; Miró O; Vidal S; Blanco JL; Garrabou G; Laguno M; Arnaiz JA; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM Antivir Ther; 2007; 12(3):407-15. PubMed ID: 17591031 [TBL] [Abstract][Full Text] [Related]
18. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963 [TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944 [TBL] [Abstract][Full Text] [Related]
20. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Nolan D; Hammond E; James I; McKinnon E; Mallal S Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]